Kaleidoscope Innovation vs Phillips-Medisize: full comparison for 2026
Quick verdict
Kaleidoscope Innovation (4.0/5) edges ahead of Phillips-Medisize (3.9/5) overall. Kaleidoscope Innovation is the better choice for enterprises already working with Infosys. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
Kaleidoscope Innovation vs Phillips-Medisize: head-to-head summary
| Criterion | Kaleidoscope Innovation | Phillips-Medisize |
|---|---|---|
| Founded | 1989 | 1964 |
| HQ | Cincinnati, OH, USA | Hudson, WI, USA |
| Team size | 100–250 | ~7,000 |
| Rating | 4.0 / 5 | 3.9 / 5 |
| Primary differentiator | US medical design studio with access to Infosys engineering and digital capacity | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Time and materials, fixed project | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | SolidWorks, Usability engineering, ISO 13485 QMS | Injection molding, Automated assembly, BLE |
| Industries served | Surgical & therapeutic devices, Diagnostics & lab devices, Consumer products | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
Kaleidoscope Innovation vs Phillips-Medisize: overview
Kaleidoscope Innovation
Kaleidoscope Innovation was founded in Cincinnati, Ohio, in 1989. Infosys acquired it in September 2020, and the deal coverage described its services as focused mainly on medical devices. It is listed as ISO 13485 certified and FDA compliant, and runs product development labs that it has expanded for healthcare clients. Headcount estimates range from about 100 to 250.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: Kaleidoscope Innovation vs Phillips-Medisize
| Capability | Kaleidoscope Innovation | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✗ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✓ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Kaleidoscope Innovation vs Phillips-Medisize
| Framework / platform | Kaleidoscope Innovation | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | N/A | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | ✓ |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Kaleidoscope Innovation vs Phillips-Medisize
| Criterion | Kaleidoscope Innovation | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Kaleidoscope Innovation vs Phillips-Medisize
| Dimension | Kaleidoscope Innovation | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Surgical & therapeutic devices, Diagnostics & lab devices, Consumer products | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Industrial and mechanical design for a surgical instrument, Device testing in an accredited lab environment | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Fixed project | Fixed project |
Kaleidoscope Innovation vs Phillips-Medisize: pros and cons
| Kaleidoscope Innovation | |
|---|---|
| + | ISO 13485 certified, with medical devices as its main focus |
| + | In-house test and prototyping labs |
| + | Infosys ownership adds software and digital scale |
| + | Over 30 years of product design work |
| - | Owned by Infosys since 2020, so pricing and contracts may follow a large IT services model |
| - | Electronics and embedded software depth is less visible than its design work |
| - | Team size data comes only from third-party estimates |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose Kaleidoscope Innovation?
A typical fit: industrial and mechanical design for a surgical instrument.
US medical design studio with access to Infosys engineering and digital capacity. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Consumer products.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: Kaleidoscope Innovation vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Kaleidoscope Innovation |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Kaleidoscope Innovation (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | Kaleidoscope Innovation |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Kaleidoscope Innovation vs Phillips-Medisize
| Use case | Kaleidoscope Innovation fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Industrial and mechanical design for a surgical instrument | Strong | Limited | Kaleidoscope Innovation |
| Device testing in an accredited lab environment | Strong | Strong | Both equally |
| Autoinjector or pen injector development and production | Limited | Strong | Phillips-Medisize |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: Kaleidoscope Innovation vs Phillips-Medisize
Kaleidoscope Innovation (4.0/5) is the stronger overall choice for most Medical Device Development projects. US medical design studio with access to Infosys engineering and digital capacity.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
Kaleidoscope Innovation vs Phillips-Medisize FAQ
Is Kaleidoscope Innovation better than Phillips-Medisize?
Kaleidoscope Innovation (4.0/5) scores higher overall, but "better" depends on your use case. Kaleidoscope Innovation's strongest advantage: ISO 13485 certified, with medical devices as its main focus. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do Kaleidoscope Innovation and Phillips-Medisize differ in pricing?
Kaleidoscope Innovation uses time and materials, fixed project pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Kaleidoscope Innovation or Phillips-Medisize?
Kaleidoscope Innovation is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Kaleidoscope Innovation and Phillips-Medisize?
Kaleidoscope Innovation's primary differentiator is: US medical design studio with access to Infosys engineering and digital capacity. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (100–250 vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Surgical & therapeutic devices, Diagnostics & lab devices vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.